Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Combining CAF regimen with fufangbanmao capsules improves thyroid cancer treatment outcomes and reduces side effects.

Plasmatherapy improves immune status in vitiligo patients, especially those with segmental vitiligo.

Always consider xanthomatous hypophysitis before deciding on pituitary surgery.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.

DcR3 helps heal wounds and regrow hair by changing macrophages to a repair-focused type.

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.

CD133+ cells are crucial for hair growth.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Monoclonal antibody B72.3 selectively reacts with certain dog tissues, mainly in the gastrointestinal and respiratory tracts.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

Dual TCR Treg cells are common in various mouse tissues and show diverse characteristics.

Dual TCR Treg cells are common in mouse tissues and vary by location.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

PDCD4 is important for controlling skin cell growth and healing.

A3 antibody helps identify key cells in rat hair follicle development.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

Enhancing Tregs can protect against alopecia areata.

Removing integrin α3β1 from hair stem cells lowers skin tumor growth by affecting CCN2 protein levels.

Tcf3 helps cells move and heal wounds by controlling lipocalin 2.

Increasing PDCD4 protein may help prevent or treat some skin cancers.

Monoclonal antibodies LT-1, LT-2, and LT-7 help diagnose certain blood cancers.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

The new ddPCR method reliably detects unwanted viruses in CAR-T cell products, ensuring their safety for patients.

Certain CD8+ T cells attack hair follicles in alopecia areata, suggesting they could be targeted for treatment.

BerEP4 and CD34 staining can help tell apart tricholemmoma from basal cell carcinoma.

IL-18 signaling helps mature Tregs move into the thymus.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.